sodium arsenite has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JH; Kim, ES; Kim, S; Lee, YY; Park, BB; Won, YW; Yoon, JS | 1 |
| Alvarez, EM; Blanco, GA; Cavaliere, V; Costantino, SN; Kornblihtt, L; Lombardo, T | 1 |
2 other study(ies) available for sodium arsenite and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Anti-leukemic effect of sodium metaarsenite (KML001) in acute myeloid leukemia with breaking-down the resistance of cytosine arabinoside.
Topics: Antimetabolites, Antineoplastic; Arsenites; Cell Line, Tumor; Cytarabine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Leukemia, Myeloid, Acute; Real-Time Polymerase Chain Reaction; Sodium Compounds | 2015 |
Synergism between arsenite and proteasome inhibitor MG132 over cell death in myeloid leukaemic cells U937 and the induction of low levels of intracellular superoxide anion.
Topics: Antineoplastic Agents; Arsenites; Burkitt Lymphoma; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Humans; Hydrogen Peroxide; Leukemia, Myeloid, Acute; Leupeptins; Reactive Oxygen Species; Sodium Compounds; Superoxides; Time Factors; U937 Cells | 2012 |